Considerations for modelling diffuse high-grade gliomas and developing clinically relevant therapies.

Higginbottom, Sarah L; Tomaskovic-Crook, Eva; Crook, Jeremy M

Higginbottom, Sarah L; Tomaskovic-Crook, Eva; Crook, Jeremy M.

Affiliation

Higginbottom SL; Intelligent Polymer Research Institute, AIIM Facility, Innovation Campus, University of Wollongong, Fairy Meadow, NSW, 2519, Australia.
Tomaskovic-Crook E; Arto Hardy Family Biomedical Innovation Hub, Chris O'Brien Lifehouse, Camperdown, NSW, 2050, Australia.
Crook JM; Intelligent Polymer Research Institute, AIIM Facility, Innovation Campus, University of Wollongong, Fairy Meadow, NSW, 2519, Australia. eva.tomaskoviccrook@lh.org.au.

Cancer Metastasis Rev ; 42(2): 507-541, 2023 06.

Article in En | MEDLINE | ID: mdl-37004686

Subject(s)

Brain Neoplasms; Glioma; Humans; Brain Neoplasms/pathology; Glioma/pathology; Cell Differentiation; Tumor Microenvironment

Key words

3D printing; Clinically relevant; Glioma stem cells; High-grade glioma; Microfluidics; Organoids; Preclinical models; Tissue engineering; Tumour microenvironment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Glioma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cancer Metastasis Rev Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google